Invesco Ltd. - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 64 filers reported holding ONCOCYTE CORP in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q1 2022$32,000
-30.4%
21,653
+1.1%
0.00%
Q4 2021$46,000
-41.0%
21,409
-2.2%
0.00%
Q3 2021$78,000
-27.8%
21,889
+16.1%
0.00%
Q2 2021$108,000
-37.6%
18,853
-43.6%
0.00%
Q1 2021$173,000
+133.8%
33,428
+7.4%
0.00%
Q4 2020$74,00031,1110.00%
Other shareholders
ONCOCYTE CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 2,982,557$5,697,0006.44%
BROADWOOD CAPITAL INC 14,716,204$28,108,0002.20%
PURA VIDA INVESTMENTS, LLC 5,983,724$11,429,0001.10%
Mesirow Financial Investment Management, Inc. 99,282$190,0000.90%
P.A.W. CAPITAL CORP 200,000$382,0000.43%
Penbrook Management LLC 215,625$412,0000.40%
EAM Investors, LLC 241,769$462,0000.10%
Private Wealth Partners, LLC 150,000$287,0000.04%
Phoenix Holdings Ltd. 292,275$597,0000.02%
ETF MANAGERS GROUP, LLC 145,650$470,0000.02%
View complete list of ONCOCYTE CORP shareholders